Promoter entities likely to sell 2.5% stake in Cipla worth Rs 2,637 crore: Report

May 14, 2024

Adani Enterprises. Share Price3037.5503:58 PM | 14 May 2024157.96(5.49%)Mahindra & Mahindra. Share Price2269.9003:58 PM | 14 May 202485.66(3.93%)Hero MotoCorp. Share ...

Tag: Okasa Pharma

Promoter entities likely to sell 2.5% stake in Cipla worth Rs 2,637 crore: Report

Stay Connected test

Hawaii officials work to address mental health challenges facing wildfire survivors

Wegovy heart health data is promising — but insurers face long road, high cost to cover obesity drugs

Contact lens maker faces lawsuit after woman said the product resulted in her losing an eye

Working-age Americans are struggling to pay for health care, even those with insurance, report finds

Contact lens maker faces lawsuit after woman said the product resulted in her losing an eye

Ethereum Price To Reclaim $1,300, What Are The Possibilities?

Tech layoffs in Southeast Asia mount as unprofitable startups seek to extend their runways

Stock market update: Stocks that hit 52-week lows on NSE in today’s trade

PFC to trade ex-dividend from Monday. Last day to buy shares for eligibility

RFK Jr. weighing FDA crackdown on food additives under Trump

The founder of the biggest gold ETF is still bullish 20 years later

Alphabet shares slide 4% following DOJ push for Google to divest Chrome

Recent News

PFC to trade ex-dividend from Monday. Last day to buy shares for eligibility

RFK Jr. weighing FDA crackdown on food additives under Trump

The founder of the biggest gold ETF is still bullish 20 years later

Alphabet shares slide 4% following DOJ push for Google to divest Chrome

Browse by Category

Recent News

PFC to trade ex-dividend from Monday. Last day to buy shares for eligibility

RFK Jr. weighing FDA crackdown on food additives under Trump